Cochlear Stock

Cochlear OCF Margin

The Operating Cash Flow Margin of Cochlear (COH.AX) as of Sep 3, 2026 is 10.14 %. In the previous year, Operating Cash Flow Margin was 17.39 % — a change of -41.69% (lower).

OCF Margin

10.14 %

YoY

-41.69%

Last updated:

Operating Cash Flow Margin of Cochlear is 2026 10.14 % . Operating Cash Flow Margin of Cochlear was 2025 17.39 % . It decreases by -41.69% lower compared to the previous year.

The Cochlear OCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF Margin
Date
OCF Margin
Jan 1, 2018
18.93 AUD
Jan 1, 2019
20.75 AUD
Jan 1, 2020
-11.95 AUD
Jan 1, 2021
17.72 AUD
Jan 1, 2022
22.84 AUD
Jan 1, 2023
18.72 AUD
Jan 1, 2024
17.39 AUD
Jan 1, 2025
10.14 AUD
The Cochlear OCF Margin history
YEAROCF MarginYoY
10.14 %-41.69%
17.39 %-7.09%
18.72 %-18.05%
22.84 %+28.89%
17.72 %-248.31%
-11.95 %-157.59%
20.75 %+9.62%
18.93 %-8.65%
20.72 %+26.53%
16.37 %-19.68%
20.39 %+47.30%
13.84 %
Access this data via the Eulerpool API

Cochlear Stock analysis

What does Cochlear do? Cochlear Ltd is an Australian-based medical technology company founded in 1981 by engineer Professor Graeme Clark. The company specializes in Cochlear implant systems and other hearing devices. Cochlear Ltd offers accessories, services, and rehabilitation training for individuals with hearing impairments. The company's products are available for both children and adults with varying degrees of hearing loss. Cochlear Ltd operates in different sectors, including Cochlear implant systems, hearing aids, and wireless accessories and streaming systems under the brand names Nucleus® and Baha®. Nucleus® systems utilize a fully implantable cochlear implant and external speech processor to convert sound into electrical signals for interpretation by the brain. Baha® systems are bone-anchored hearing devices for individuals with unilateral to moderate hearing impairments. Cochlear Ltd also provides wireless accessories and streaming systems to connect devices like mobile phones, TVs, and music players to the hearing aids and cochlear implants, improving hearing performance and enhancing social lives. The company has a strong global presence, operating in over 100 countries with headquarters in Australia, multiple production facilities, and research centers. Cochlear Ltd has received numerous awards and recognition for its products and services and is committed to researching and developing new therapies and technologies to improve the lives of individuals with hearing impairments. Cochlear is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cochlear stock

Operating Cash Flow Margin of Cochlear is 10.14 % in 2026.

Operating Cash Flow Margin of Cochlear changed from 17.39 % to 10.14 %, representing a -41.69% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Margin Cochlear since 2006 – with annual values, charts, and detailed analysis.

OCF margin measures the percentage of revenue converted into operating cash flow. It indicates cash generation efficiency from core business operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow Margin's Cochlear with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Cash Flow Margin.

Access this data via the Eulerpool API

Margins — Cochlear

All Key Metrics — Cochlear